DUBLIN--(BUSINESS WIRE)--Sep 21, 2022--
The "Global Drug Eluting Balloon Market (2022-2027) by Type, Technology, End-user, and Geography, with Competitive Analysis, Impact of COVID-19, and Ansoff Analysis" report has been added to ResearchAndMarkets.com's offering.
The Global Drug Eluting Balloon Market is estimated to be worth USD 853.7 million in 2022, and is expected to reach USD 1,644.45 million by 2027, growing at a CAGR of 14.01%.
Market Segmentation
The Global Drug Eluting Balloon Market is segmented based on Type, Technology, End-user, and Geography.
- By Type, the market is classified into Coronary Drug Eluting Balloon and Peripheral Drug Eluting Balloon.
- By Technology, the market is classified into EnduraCoat, FreePac, Paccocath and TransPax.
- By End-user, the market is classified into Ambulatory Surgery Centers, Cath Labs, and Hospitals.
- By Geography, the market is classified into Americas, Europe, Middle-East & Africa, and Asia-Pacific.
Countries Studied
- Americas (Argentina, Brazil, Canada, Chile, Colombia, Mexico, Peru, United States, Rest of Americas)
- Europe (Austria, Belgium, Denmark, Finland, France, Germany, Italy, Netherlands, Norway, Poland, Russia, Spain, Sweden, Switzerland, United Kingdom, Rest of Europe)
- Middle-East and Africa (Egypt, Israel, Qatar, Saudi Arabia, South Africa, United Arab Emirates, Rest of MEA)
- Asia-Pacific (Australia, Bangladesh, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Sri Lanka, Thailand, Taiwan, Rest of Asia-Pacific)
The Competitive Quadrant
The report includes the Competitive Quadrant, a proprietary tool to analyze and evaluate the position of companies based on their Industry Position score and Market Performance score. The tool uses various factors for categorizing the players into four categories. Some of these factors considered for analysis are financial performance over the last 3 years, growth strategies, innovation score, new product launches, investments, growth in market share, etc.
Ansoff Analysis
- The report presents a detailed Ansoff matrix analysis for the Global Drug Eluting Balloon Market. Ansoff Matrix, also known as Product/Market Expansion Grid, is a strategic tool used to design strategies for the growth of the company. The matrix can be used to evaluate approaches in four strategies viz. Market Development, Market Penetration, Product Development and Diversification. The matrix is also used for risk analysis to understand the risk involved with each approach.
- The Global Drug Eluting Balloon Market is analyzed using the Ansoff Matrix to provide the best approaches a company can take to improve its market position.
- Based on the SWOT analysis conducted on the industry and industry players, suitable strategies have been devised for market growth.
Why Buy This Report?
- The report offers a comprehensive evaluation of the Global Drug Eluting Balloon Market. The report includes in-depth qualitative analysis, verifiable data from authentic sources, and projections about market size. The projections are calculated using proven research methodologies.
- The report has been compiled through extensive primary and secondary research. The primary research is done through interviews, surveys, and observation of renowned personnel within the industry.
- The report includes an in-depth market analysis using Porter's 5 forces model and the Ansoff Matrix. In addition, the impact of COVID-19 on the market is also featured in the report.
- The report also includes the regulatory scenario within the industry, which will help you make a well-informed decision. The report discusses major regulatory bodies and major rules & regulations imposed on this sector across various geographies.
- The report also contains competitive analysis using 'Positioning Quadrants'; a proprietary competitive positioning tool.
Market Dynamics
Drivers
- Increasing Geriatric Population Leading to Cardiovascular Diseases
- Rising Occurrence of Peripheral and Coronary Artery Diseases
Restraints
- Issues Associated with Product Recalls of Drug-Eluting Balloons
Opportunities
- New Developments in the Clinical Use of Drug-coated Balloon Catheter
- Advancement, Innovation, and Research in Drug-coated Balloons
Challenges
- Lack of Availability for Skilled and Trained Professionals
Key Topics Covered:
1 Report Description
2 Research Methodology
3 Executive Summary
4 Market Dynamics
5 Market Analysis
6 Global Drug Eluting Balloon Market, by Type
7 Global Drug Eluting Balloon Market, by Technology
8 Global Drug Eluting Balloon Market, by End-user
9 Americas' Drug Eluting Balloon Market
10 Europe's Drug Eluting Balloon Market
11 Middle East and Africa's Drug Eluting Balloon Market
12 APAC's Drug Eluting Balloon Market
13 Competitive Landscape
14 Company Profiles
15 Appendix
Companies Mentioned
- Abbott Laboratories
- B. Braun Melsungen AG
- Bayer AG
- Becton, Dickinson and Co.
- Biosensors International Group, Ltd.
- BioSpace, Inc.
- Biotronik SE & Co. KG
- Boston Scientific Corporation
- Cardionovum GmbH
- Concept Medical, Inc.
- Cook Group Inc.
- Eurocor Tech GmbH
- Innvolution Healthcare Pvt. Ltd.
- iVascular S.L.U.
- Koninklijke Philips N.V.
- M.A. Med Alliance SA
- Medtronic PLC
- MicroPort Opto Circuits Ltd.
- SurModics, Inc.
- Terumo Corp.
For more information about this report visit https://www.researchandmarkets.com/r/256dmj
View source version on businesswire.com:https://www.businesswire.com/news/home/20220921005771/en/
CONTACT: ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
KEYWORD:
